Anxiety and fear related to coronavirus disease 2019 assessment in the Spanish population: A cross-sectional study.
Anxiety
coronavirus disease 2019
fear
public health
questionnaire
stress
survey
Journal
Science progress
ISSN: 2047-7163
Titre abrégé: Sci Prog
Pays: England
ID NLM: 0411361
Informations de publication
Date de publication:
Historique:
entrez:
26
8
2021
pubmed:
27
8
2021
medline:
10
9
2021
Statut:
ppublish
Résumé
The coronavirus disease 2019 pandemic has affected millions of people worldwide, compromising the responsiveness of governments and states and thus generating anxiety and fear at the population level. To assess the level of anxiety and fear of coronavirus disease 2019 in a Spanish adult population group. A descriptive cross-sectional study, using the anxiety and fear of COVID-19 assessment scale (AMICO, for its acronym in Spanish). The sample was composed of 1038 subjects. Univariate and bivariate statistical analyses were performed, after analysis of normality in the data distribution. Categorical regression analyses were also executed. The total sample size was 1036 subjects, 56.3% was made up of females, with a mean age of 48.11 years (SD = 15.13). The mean score obtained on the AMICO scale was 5.54 points (SD = 1.83), with a score range between 1.22 and 10. Bivariate analysis only demonstrated statistically significant differences in the mean score of the scale and the variables: sex, marital status, work area and academic level. The executed categorical regression analysis revealed an The results obtained show that the Spanish population presents moderate anxiety levels to coronavirus disease 2019. Women, married, with primary and/or secondary education level, and working in the public transport, services and/or hospitality sectors are more likely to have high levels of fear and anxiety. These results could be used for therapeutic and preventive psychological interventions, and also to plan new research under sex perspective and observing the socio-economic environment.
Sections du résumé
BACKGROUND
The coronavirus disease 2019 pandemic has affected millions of people worldwide, compromising the responsiveness of governments and states and thus generating anxiety and fear at the population level.
OBJECTIVE
To assess the level of anxiety and fear of coronavirus disease 2019 in a Spanish adult population group.
METHODS
A descriptive cross-sectional study, using the anxiety and fear of COVID-19 assessment scale (AMICO, for its acronym in Spanish). The sample was composed of 1038 subjects. Univariate and bivariate statistical analyses were performed, after analysis of normality in the data distribution. Categorical regression analyses were also executed.
FINDINGS
The total sample size was 1036 subjects, 56.3% was made up of females, with a mean age of 48.11 years (SD = 15.13). The mean score obtained on the AMICO scale was 5.54 points (SD = 1.83), with a score range between 1.22 and 10. Bivariate analysis only demonstrated statistically significant differences in the mean score of the scale and the variables: sex, marital status, work area and academic level. The executed categorical regression analysis revealed an
CONCLUSIONS
The results obtained show that the Spanish population presents moderate anxiety levels to coronavirus disease 2019. Women, married, with primary and/or secondary education level, and working in the public transport, services and/or hospitality sectors are more likely to have high levels of fear and anxiety.
APPLICATION TO PRACTICE
These results could be used for therapeutic and preventive psychological interventions, and also to plan new research under sex perspective and observing the socio-economic environment.
Identifiants
pubmed: 34435895
doi: 10.1177/00368504211038191
pmc: PMC10361589
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
368504211038191Références
Rev Esp Salud Publica. 2020 Jun 08;94:
pubmed: 32507849
J Affect Disord. 2020 Dec 1;277:55-64
pubmed: 32799105
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Brain Behav Immun. 2020 Jul;87:84-92
pubmed: 32335200
Sleep Med. 2020 Nov;75:315-325
pubmed: 32950013
Sci Rep. 2021 Mar 19;11(1):6481
pubmed: 33742072
Rev Peru Med Exp Salud Publica. 2020 Apr-Jun;37(2):327-334
pubmed: 32876225
BMC Infect Dis. 2014 Mar 27;14:169
pubmed: 24674239
Rev Clin Esp. 2020 Mar 20;:
pubmed: 32204922
Int J Environ Res Public Health. 2020 Mar 19;17(6):
pubmed: 32204411
Cell. 2020 Aug 6;182(3):713-721.e9
pubmed: 32778225
Front Psychol. 2020 Sep 11;11:565153
pubmed: 33041928
Gac Sanit. 2021 Nov-Dec;35(6):594-597
pubmed: 32553483
Int J Environ Res Public Health. 2020 Jun 02;17(11):
pubmed: 32498401
Int J Nurs Sci. 2020 Apr 04;7(2):128-134
pubmed: 32292634
Arch Iran Med. 2020 Apr 01;23(4):268-271
pubmed: 32271601
Aten Primaria. 2021 Mar;53(3):101956
pubmed: 33592533
J Behav Ther Exp Psychiatry. 2019 Mar;62:57-64
pubmed: 30219564
Brain Sci. 2021 Mar 05;11(3):
pubmed: 33807643
Int J Surg. 2020 Jun;78:185-193
pubmed: 32305533
BJPsych Open. 2020 Oct 08;6(6):e116
pubmed: 33028449
Cad Saude Publica. 2020 Apr 30;36(4):e00054020
pubmed: 32374806
PLoS One. 2021 Feb 11;16(2):e0246824
pubmed: 33571297
Rev Derecho Genoma Hum. 2007 Jan-Jun;(26):283-325
pubmed: 18201045
PLoS One. 2017 Mar 8;12(3):e0173234
pubmed: 28273131
Psychiatry Res. 2020 May;287:112934
pubmed: 32229390
Sci Prog. 2021 Oct;104(4):368504211050291
pubmed: 34698544
Gac Med Mex. 2020;156(4):298-305
pubmed: 32831341
Int J Environ Res Public Health. 2020 Mar 06;17(5):
pubmed: 32155789
Transl Psychiatry. 2020 Oct 19;10(1):355
pubmed: 33077738
Front Psychiatry. 2020 Sep 09;11:569981
pubmed: 33033485
Rev Esp Salud Publica. 2020 Jul 23;94:
pubmed: 32699204
Ann Acad Med Singap. 2020 Jan;49(3):155-160
pubmed: 32200399
Brain Behav Immun. 2020 Jul;87:40-48
pubmed: 32298802
Int J Behav Med. 2009;16(1):7-29
pubmed: 19214752